Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine for Gastrointestinal Dysfunction in Neurosurgery
NCT07650812Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jul 2026
- Primary completion
- Dec 2027
01
Overview
Randomised trial of oliceridine in Digestive tract dysfunction (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: High risk rate of gastrointestinal dysfunction at 72 hours. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
Digestive tract dysfunction
Beyond the preview
Go deeper on NCT07650812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07650812.